Rheumatic heart disease (RHD) is a long-term consequence of rheumatic fever, an inflammatory disease that can develop after a strep throat or scarlet fever infection. When left untreated, the inflammation caused by rheumatic fever can damage the heart valves, leading to complications such as valve stenosis or regurgitation. While the disease was once common in many parts of the world, its prevalence has decreased significantly in developed countries due to widespread use of antibiotics to treat strep throat. However, RHD remains a major concern in low- and middle-income nations, where access to medical care and prevention programs is limited. Early detection and appropriate treatment of streptococcal throat infections are crucial in preventing the development of rheumatic heart disease.
Title : Novel mechanisms and new therapeutics for right heart failure in pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China